International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update.

doi:10.1016/j.jcin.2024.08.027

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update.

JACC. Cardiovascular interventions - 25 Nov 2024

Angiolillo Dominick J, Galli Mattia, Alexopoulos Dimitrios, Aradi Daniel, Bhatt Deepak L, Bonello Laurent, Capodanno Davide, Cavallari Larisa H, Collet Jean-Philippe, Cuisset Thomas, Ferreiro Jose Luis, Franchi Francesco, Geisler Tobias, Gibson C Michael, Gorog Diana A, Gurbel Paul A, Jeong Young-Hoon, Marcucci Rossella, Siller-Matula Jolanta M, Mehran Roxana, Neumann Franz-Josef, Pereira Naveen L, Rizas Konstantinos D, Rollini Fabiana, So Derek Y F, Stone Gregg W, Storey Robert F, Tantry Udaya S, Berg Jurrien Ten, Trenk Dietmar, Valgimigli Marco, Waksman Ron, Sibbing Dirk

Abstract excerpt

Current evidence indicates that dual antiplatelet therapy with aspirin plus a P2Y12 inhibitor is essential for the prevention of thrombotic events after percutaneous coronary interventions. However, dual antiplatelet therapy is associated with increased bleeding which may outweigh the benefits. This has set the foundations for customizing antiplatelet treatments to the individual patient. However, bleeding and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Decision-Making

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Thrombosis

Share to Hemorrhage

Share to Percutaneous Coronary Intervention

Share to Pharmacogenomic Testing

Share to Pharmacogenomic Variants

Share to Platelet Function Tests

Share to Purinergic P2Y Receptor Antagonists

Source

Open in PubMed

Identifiers

PMID: 39603778
DOI: 10.1016/j.jcin.2024.08.027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update.PMID 39603778Read ↗

Personalized antiplatelet therapy: a scoping review on the role of platelet function testing and genotyping in acute coronary syndrome.Semantic proximity Read ↗

Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention.Semantic proximity Read ↗

Most Recent Evidence Behind Aggregometry and Genotyping Methods as Platelet Function Testing for Tailored Anti-Platelet Treatment Among PCI Patients.Semantic proximity Read ↗

Platelet function and antiplatelet therapy in cardiovascular disease: implications of genetic polymorphisms.Semantic proximity Read ↗

Influence of genetic polymorphisms on platelet function, response to antiplatelet drugs and clinical outcomes in patients with coronary artery disease.Semantic proximity Read ↗

Pharmacogenetics of Antiplatelet Therapy.Semantic proximity Read ↗

Optimal aNtiplatelet pharmacotherapy guided by bedSIDE genetic or functional TESTing in elective PCI patients: A pilot study: ONSIDE TEST pilot.Semantic proximity Read ↗

2025 Acute Coronary Syndrome Guideline: Missing the Boat on CYP2C19 Genotyping.Semantic proximity Read ↗

Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents?: the role of platelet reactivity and genotype testing in the prevention of atherothrombotic cardiovascular events remains unproven.Semantic proximity Read ↗

What is the role of genetic testing in the investigation of patients with suspected platelet function disorders?Semantic proximity Read ↗

Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE study.Semantic proximity Read ↗

Personalizing antiplatelet therapy with clopidogrel.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.